Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) Gross Profit (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Gross Profit for 8 consecutive years, with $145.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Gross Profit rose 6.09% to $145.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $629.3 million, a 0.69% decrease, with the full-year FY2025 number at $629.3 million, down 0.69% from a year prior.
  • Gross Profit was $145.8 million for Q4 2025 at Select Medical Holdings, down from $147.4 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $272.6 million in Q2 2021 to a low of -$1.3 billion in Q4 2023.
  • A 5-year average of $87.9 million and a median of $156.3 million in 2021 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: plummeted 687.18% in 2023, then surged 110.97% in 2024.
  • Select Medical Holdings' Gross Profit stood at $157.2 million in 2021, then tumbled by 201.25% to -$159.2 million in 2022, then tumbled by 687.18% to -$1.3 billion in 2023, then soared by 110.97% to $137.5 million in 2024, then increased by 6.09% to $145.8 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Gross Profit are $145.8 million (Q4 2025), $147.4 million (Q3 2025), and $155.4 million (Q2 2025).